208 related articles for article (PubMed ID: 11984083)
1. Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro.
Maier G; Fiebig HH
Anticancer Drugs; 2002 Apr; 13(4):373-9. PubMed ID: 11984083
[TBL] [Abstract][Full Text] [Related]
2. Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro.
Kelter G; Fiebig HH
Arzneimittelforschung; 2006 Jun; 56(6A):435-40. PubMed ID: 16927523
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles of different breast cancer cells compared with their responsiveness to fermented mistletoe (Viscum album L.) extracts Iscador from oak (Quercus), pine (Pinus), white fir (Abies) and apple tree (Malus) in vitro.
Eggenschwiler J; Patrignani A; Wagner U; Rehrauer H; Schlapbach R; Rist L; Ramos MH; Viviani A
Arzneimittelforschung; 2006 Jun; 56(6A):483-96. PubMed ID: 16927530
[TBL] [Abstract][Full Text] [Related]
4. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.
Urech K; Schaller G; Jäggy C
Arzneimittelforschung; 2006 Jun; 56(6A):428-34. PubMed ID: 16927522
[TBL] [Abstract][Full Text] [Related]
5. Effects of mistletoe (Viscum album L.) extracts Iscador on cell cycle and survival of tumor cells.
Harmsma M; Ummelen M; Dignef W; Tusenius KJ; Ramaekers FC
Arzneimittelforschung; 2006 Jun; 56(6A):474-82. PubMed ID: 16927529
[TBL] [Abstract][Full Text] [Related]
6. Human cancer cells exhibit in vitro individual receptiveness towards different mistletoe extracts.
Knöpfl-Sidler F; Viviani A; Rist L; Hensel A
Pharmazie; 2005 Jun; 60(6):448-54. PubMed ID: 15997835
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
Felenda JE; Turek C; Stintzing FC
J Ethnopharmacol; 2019 May; 236():100-107. PubMed ID: 30840914
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro.
Kelter G; Schierholz JM; Fischer IU; Fiebig HH
Anticancer Res; 2007; 27(1A):223-33. PubMed ID: 17352237
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic effects of mistletoe (Viscum album L.) in head and neck squamous cell carcinoma cell lines.
Klingbeil MF; Xavier FC; Sardinha LR; Severino P; Mathor MB; Rodrigues RV; Pinto DS
Oncol Rep; 2013 Nov; 30(5):2316-22. PubMed ID: 24026291
[TBL] [Abstract][Full Text] [Related]
10. Cytostatic and cytocidal effects of mistletoe (Viscum album L.) quercus extract Iscador.
Kovacs E; Link S; Toffol-Schmidt U
Arzneimittelforschung; 2006 Jun; 56(6A):467-73. PubMed ID: 16927528
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts Iscador.
Elluru S; Duong Van Huyen JP; Delignat S; Prost F; Bayry J; Kazatchkine MD; Kaveri SV
Arzneimittelforschung; 2006 Jun; 56(6A):461-6. PubMed ID: 16927527
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
Ribéreau-Gayon G; Jung ML; Di Scala D; Beck JP
Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
[TBL] [Abstract][Full Text] [Related]
14. Immune modulation using mistletoe (Viscum album L.) extracts Iscador.
Büssing A
Arzneimittelforschung; 2006 Jun; 56(6A):508-15. PubMed ID: 16927532
[TBL] [Abstract][Full Text] [Related]
15. Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro.
Stein G; Berg PA
Eur J Clin Pharmacol; 1994; 47(1):33-8. PubMed ID: 7988621
[TBL] [Abstract][Full Text] [Related]
16. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R
Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties.
Holtskog R; Sandvig K; Olsnes S
Oncology; 1988; 45(3):172-9. PubMed ID: 3368193
[TBL] [Abstract][Full Text] [Related]
18. Preclinical investigations with mistletoe (Viscum album L.) extract Iscador.
Maldacker J
Arzneimittelforschung; 2006 Jun; 56(6A):497-507. PubMed ID: 16927531
[TBL] [Abstract][Full Text] [Related]
19. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
[TBL] [Abstract][Full Text] [Related]
20. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
